Rapid Diagnostic Profiling of SARS-CoV-2 (COVID-19)
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to SARS-CoV-2
Related studies linked through entity extraction aliases.
Efficacy of Iodine Complex Against COVID-19 Patients
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Epidemiologic Assessment of SARS-CoV-2 (COVID-19) Prevalence in Minnesota
- Status
- WITHDRAWN
- Phase
- N/A
Colchicine/Statins for the Prevention of COVID-19 Complications (COLSTAT) Trial
- Status
- COMPLETED
- Phase
- PHASE3
Study of Abatacept in the Treatment of Hospitalized COVID-19 Participants With Respiratory Compromise
- Status
- TERMINATED
- Phase
- PHASE2
Seroprevalence of Coronavirus Disease 2019 (COVID-19) Antibodies in a Vulnerable Neighbourhood, Buenos Aries Argentina
- Status
- COMPLETED
- Phase
- N/A
Changes in Cellular Immune Profile During COVID-19 Infection
- Status
- SUSPENDED
- Phase
- NA
A Study to Evaluate Efficacy, Safety, and Immunogenicity of mRNA-1273 Vaccine in Adults Aged 18 Years and Older to Prevent COVID-19
- Status
- COMPLETED
- Phase
- PHASE3
Assessment of Olfactory Dysfunction in SARS CoV-2 (COVID-19) Infection
- Status
- COMPLETED
- Phase
- N/A
Antibody Detection in COVID-19 Cured Patients (SARS-CoV-2-CZ-Immunity)
- Status
- COMPLETED
- Phase
- N/A
Multicentric Registry of Patients With Acute Leukemia Infected by COVID-19
- Status
- COMPLETED
- Phase
- N/A
A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults for COVID-19
- Status
- COMPLETED
- Phase
- PHASE1
Control of COVID-19 Outbreaks in Long Term Care
- Status
- TERMINATED
- Phase
- PHASE2
DUR-928 in Subjects With SARS-CoV-2 With Acute Lung, Liver or Kidney Injury
- Status
- TERMINATED
- Phase
- PHASE2
Effect of COVID-19 on Platelet Aggregation
- Status
- COMPLETED
- Phase
- N/A
ANalyzing Olfactory Dysfunction Mechanisms In COVID-19
- Status
- UNKNOWN
- Phase
- NA
Safety and Immunogenicity Study of GX-19, a COVID-19 Preventive DNA Vaccine in Healthy Adults
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Oncological Surgery in Times of COVID-19: Effectiveness of Preoperative Screening for Sars-Cov-2
- Status
- UNKNOWN
- Phase
- N/A
Pemziviptadil (PB1046), a Long-acting, Sustained Release Human VIP Analogue, Intended to Provide Clinical Improvement to Hospitalized COVID-19 Patients at High Risk for Rapid Clinical Deterioration and Acute Respiratory Distress Syndrome (ARDS).
- Status
- TERMINATED
- Phase
- PHASE2
RepurpoSing Old Drugs TO SuppRess a Modern Threat: COVID-19 STORM
- Status
- WITHDRAWN
- Phase
- PHASE2